☰

Mahalakshmi Shankaran, Ph.D. - Publications

Affiliations: 
University of Cincinnati, Cincinnati, OH 
Area:
Neuropharmacology of amphetamines
Tree Info Grants Similar researchers PubMed Report error

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Shankaran M, Shearer TW, Stimpson SA, Turner SM, King C, Wong PA, Shen Y, Turnbull PS, Kramer F, Clifton L, Russell AJ, Hellerstein MK, Evans WJ. Proteome-wide muscle protein fractional synthesis rates predict muscle mass gain in response to a selective androgen receptor modulator in rats. American Journal of Physiology. Endocrinology and Metabolism. ajpendo.00257.2015. PMID 26714847 DOI: 10.1152/Ajpendo.00257.2015  0.32
2005 Chen Z, Tetzlaff J, Sripathirathan K, Carrasco GA, Shankaran M, Van De Kar LD, Muma NA, Battaglia G. Paroxetine is effective in desensitizing 5-HT1A receptor function in adult offspring exposed prenatally to cocaine. Psychopharmacology. 180: 316-26. PMID 15864558 DOI: 10.1007/S00213-005-2249-8  0.427
2003 Damjanoska KJ, Muma NA, Zhang Y, D'Souza DN, Garcia F, Carrasco GA, Kindel GH, Haskins KA, Shankaran M, Petersen BR, Van De Kar LD. Neuroendocrine evidence that (S)-2-(chloro-5-fluoro-indol- l-yl)-1-methylethylamine fumarate (Ro 60-0175) is not a selective 5-hydroxytryptamine(2C) receptor agonist. The Journal of Pharmacology and Experimental Therapeutics. 304: 1209-16. PMID 12604698 DOI: 10.1124/Jpet.102.043489  0.469
2002 Darvesh AS, Shankaran M, Gudelsky GA. 3,4-Methylenedioxymethamphetamine produces glycogenolysis and increases the extracellular concentration of glucose in the rat brain. The Journal of Pharmacology and Experimental Therapeutics. 301: 138-44. PMID 11907167 DOI: 10.1124/Jpet.301.1.138  0.64
2001 Shankaran M, Yamamoto BK, Gudelsky GA. Ascorbic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5-HT. Synapse (New York, N.Y.). 40: 55-64. PMID 11170222 DOI: 10.1002/1098-2396(200104)40:1<55::Aid-Syn1026>3.0.Co;2-O  0.656
1999 Shankaran M, Yamamoto BK, Gudelsky GA. Involvement of the serotonin transporter in the formation of hydroxyl radicals induced by 3,4-methylenedioxymethamphetamine. European Journal of Pharmacology. 385: 103-10. PMID 10607865 DOI: 10.1016/S0014-2999(99)00728-1  0.659
1999 Shankaran M, Gudelsky GA. A neurotoxic regimen of MDMA suppresses behavioral, thermal and neurochemical responses to subsequent MDMA administration. Psychopharmacology. 147: 66-72. PMID 10591870 DOI: 10.1007/S002130051143  0.666
1999 Shankaran M, Yamamoto BK, Gudelsky GA. Mazindol attenuates the 3,4-methylenedioxymethamphetamine-induced formation of hydroxyl radicals and long-term depletion of serotonin in the striatum. Journal of Neurochemistry. 72: 2516-22. PMID 10349862 DOI: 10.1046/J.1471-4159.1999.0722516.X  0.65
1998 Shankaran M, Gudelsky GA. Effect of 3,4-methylenedioxymethamphetamine (MDMA) on hippocampal dopamine and serotonin. Pharmacology, Biochemistry, and Behavior. 61: 361-6. PMID 9802829 DOI: 10.1016/S0091-3057(98)00103-8  0.641
Show low-probability matches.